Write your message
Volume 18, Issue 2 (Iranian Journal of Breast Diseases 2025)                   ijbd 2025, 18(2): 87-104 | Back to browse issues page


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Imani M, Lotfi H, Abdolvahab M, Mohajeri N. Synthesis and Biological Assessment of Imidazole-Enhanced DNA Dots for Breast Cancer Cell Imaging. ijbd 2025; 18 (2) :87-104
URL: http://ijbd.ir/article-1-1145-en.html
1- School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran
2- Cellular and Molecular Research Center, Research Institute for Prevention of Non-Communicable Disease, Qazvin University of Medical Sciences, Qazvin, Iran
3- Recombinant Proteins Department, Breast Cancer Research Center, Motamed Cancer Institute, Academic Center for Education, Culture and Research, Tehran, Iran
4- Recombinant Proteins Department, Breast Cancer Research Center, Motamed Cancer Institute, Academic Center for Education, Culture and Research, Tehran, Iran , Mohajeri.nasrin@gmail.com
Abstract:   (383 Views)
Background: Breast cancer (BC) remains one of the most prevalent malignancies among women worldwide. Early detection of BC is crucial as it significantly increases the chances of successful treatment and reduces mortality rates. Fluorescence imaging holds significant promise for the early detection of BC.
Methods: DNA-Imidazole dots (DI-dot) were synthesized through the facile hydrothermal method using DNA and imidazole as a heterocyclic function group. The physicochemical, structural, and fluorescent characteristics of DI-dot were analyzed by Fourier transform infrared spectroscopy (FTIR), scanning electron microscopy, transmission electron microscopy, and energy-dispersive X-ray spectroscopy (EDAX). Spectroscopic features were investigated by the ultraviolet absorption and fluorescence spectra. Analysis of FTIR spectroscopy, size, and zeta potential verified the synthesis and modification of DI-dot. The UV-visibility and fluorescence intensity of the DI-dot showed great optical properties under a radiation of 360 nm.
Results: The DI-dot was synthesized with high yields (34%). Average diameter of monodispersed DI-dots was within the range of 6-10 nm. The EDAX results determined the preservation of DNA moieties within the secondary structure of the DI-dot modified by imidazole. The FTIR analysis further identified the NH and C-N bonds, corresponding to the enhanced fluorescence efficiency of the DI-dot. The DI-dot showed two distinctively sharp fluorescence peaks at 400–500 nm, with maximum absorption at 260 nm. The cytotoxicity assay ensured the high viability (88%) of the MDA-MB-231 breast cancer cell line.
Conclusion: The DI-dot represented superior fluorescent properties and significant stability under strange conditions, including long-term UV exposure, different pH solutions, and high ionic concentrations. Ultimately, DI-dots can be used for fluorescence imaging of MDA-MB-231 breast cancer cells due to their enhanced fluorescence properties and high biocompatibility.
Full-Text [PDF 1777 kb]   (62 Downloads)    
Type of Study: Research | Subject: Diagnosis, treatment, rehabilitation
Received: 2024/10/13 | Accepted: 2025/03/5 | Published: 2025/07/1

References
1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-49. [DOI:10.3322/caac.21660] [PMID]
2. Agarwal H, Bynum RC, Saleh N, Harris D, MacCuaig WM, Kim V, et al. Theranostic nanoparticles for detection and treatment of pancreatic cancer. Wiley Interdiscip Rev Nanomedicine Nanobiotechnology. 2024;16(4):e1983. [DOI:10.1002/wnan.1983] [PMID] []
3. Altinbasak I, Alp Y, Sanyal R, Sanyal A. Theranostic nanogels: multifunctional agents for simultaneous therapeutic delivery and diagnostic imaging. Nanoscale. 2024; [DOI:10.1039/D4NR01423E] [PMID]
4. Wan X, Zhang Y, Wan Y, Xiong M, Xie A, Liang Y, et al. A Multifunctional Biomimetic Nanoplatform for Dual Tumor Targeting-Assisted Multimodal Therapy of Colon Cancer. ACS Nano. 2024; [DOI:10.1021/acsnano.4c05773] [PMID]
5. Liu G, Tian X, Shen R, Li C, Wang Z, Sha X, et al. Double metal nanoparticles loaded and NIR/pH dual responsive drug nanocrystals inhibit cancer stem cells in a multi-modal manner. Appl Mater Today. 2024;39:102272. [DOI:10.1016/j.apmt.2024.102272]
6. Zhu P, Liu Y, Tang Y, Zhu S, Liu X, Yin L, et al. Bi-doped carbon quantum dots functionalized liposomes with fluorescence visualization imaging for tumor diagnosis and treatment. Chinese Chem Lett. 2024;35(4):108689. [DOI:10.1016/j.cclet.2023.108689]
7. Yin Q, Gao X, Zhang H, Zhang Z, Yu X, He J, et al. Fe3O4-Cy5. 5-trastuzumab magnetic nanoparticles for magnetic resonance/near-infrared imaging targeting HER2 in breast cancer. Biomed Mater. 2024;19(3):35034. [DOI:10.1088/1748-605X/ad3f61] [PMID]
8. Son T, Kim M, Choi M, Nam SH, Yoo A, Lee H, et al. Advancing fluorescence imaging: enhanced control of cyanine dye-doped silica nanoparticles. J Nanobiotechnology. 2024;22(1):347. [DOI:10.1186/s12951-024-02638-7] [PMID] []
9. Puvvada N, Shaik MAS, Samanta D, Shaw M, Mondal I, Basu R, et al. Biocompatible fluorescent carbon nanoparticles as nanocarriers for targeted delivery of tamoxifen for regression of Breast carcinoma. Spectrochim Acta Part A Mol Biomol Spectrosc. 2024;321:124721. [DOI:10.1016/j.saa.2024.124721] [PMID]
10. Wang Z, Liao H, Wu H, Wang B, Zhao H, Tan M. Fluorescent carbon dots from beer for breast cancer cell imaging and drug delivery. Anal Methods. 2015;7(20):8911-7. [DOI:10.1039/C5AY01978H]
11. Hui S. Carbon dots (CDs): basics, recent potential biomedical applications, challenges, and future perspectives. J Nanoparticle Res. 2023;25(4):68. [DOI:10.1007/s11051-023-05701-w]
12. Yan X, Zhao H, Zhang K, Zhang Z, Chen Y, Feng L. Chiral Carbon Dots: Synthesis and Applications in Circularly Polarized Luminescence, Biosensing and Biology. Chempluschem. 2023;88(1):e202200428. [DOI:10.1002/cplu.202200428] [PMID]
13. Shinde VR, Khatun S, Thanekar AM, Hak A, Rengan AK. Lipid-coated red fluorescent carbon dots for imaging and synergistic phototherapy in breast cancer. Photodiagnosis Photodyn Ther. 2023;41:103314. [DOI:10.1016/j.pdpdt.2023.103314] [PMID]
14. Mohammed J, Desu PK, Namratha JR, Rao GK. Applications of carbon dots (CDs) in drug delivery. Adv Pharmacol Pharm. 2023;11(1):36-45. [DOI:10.13189/app.2023.110104]
15. Xiong W, Meng XF, Zhang C. Inflammasome activation in podocytes: a new mechanism of glomerular diseases. Inflamm Res. 2020;69(8):731-43. [DOI:10.1007/s00011-020-01354-w] [PMID]
16. Zhao X, Wang H, Feng Y, Li H, Liu Q, Chen X. Self-propelled quantum dots-based spherical nucleic amplifier for ratiometric imaging of intracellular microRNAs. Sensors Actuators B Chem. 2023;374:132802. [DOI:10.1016/j.snb.2022.132802]
17. Zu F, Yan F, Bai Z, Xu J, Wang Y, Huang Y, et al. The quenching of the fluorescence of carbon dots: A review on mechanisms and applications. Microchim Acta. 2017;184(7):1899-914. [DOI:10.1007/s00604-017-2318-9]
18. Rania RSP, Venkatesha T, Satyanarayanb ND, Nippub BN. Current Chemistry Letters. 2023;
19. Soni A, Palia P, Sharma P. Synthesis, Characterization of various Imidazole-1, 3, 4-Oxadiazole Derivative. J Pharma Drug Regul Aff (e-ISSN 2582-3043). 2022;1-15.
20. Wang J, Ding X, Lan Z, Liu G, Hou S, Hou S. Imidazole Compounds: Synthesis, Characterization and Application in Optical Analysis. Crit Rev Anal Chem. 2021;1-26. [DOI:10.1080/10408347.2021.2023459] [PMID]
21. Siwach A, Verma PK. Synthesis and therapeutic potential of imidazole containing compounds. BMC Chem. 2021;15(1):12. [DOI:10.1186/s13065-020-00730-1] [PMID] []
22. Zhang BT, Liu H, Liu Y, Teng Y. Application trends of nanofibers in analytical chemistry. TrAC Trends Anal Chem. 2020;131:115992. [DOI:10.1016/j.trac.2020.115992]
23. Hashemi F, Heidari F, Mohajeri N, Mahmoodzadeh F, Zarghami N. Fluorescence Intensity Enhancement of Green Carbon Dots: Synthesis, Characterization and Cell Imaging. Photochem Photobiol. 2020;96(5):1032-40. [DOI:10.1111/php.13261] [PMID]
24. Whitfield CJ, Zhang M, Winterwerber P, Wu Y, Ng DYW, Weil T. Functional DNA-polymer conjugates. Chem Rev. 2021;121(18):11030-84. [DOI:10.1021/acs.chemrev.0c01074] [PMID] []
25. Cheung YW, Röthlisberger P, Mechaly AE, Weber P, Levi-Acobas F, Lo Y, et al. Evolution of abiotic cubane chemistries in a nucleic acid aptamer allows selective recognition of a malaria biomarker. Proc Natl Acad Sci. 2020;117(29):16790-8. [DOI:10.1073/pnas.2003267117] [PMID] []
26. Imani M, Mohajeri N, Rastegar M, Zarghami N. Synthesis and characterization of N-rich fluorescent bio-dots as a reporter in the design of dual-labeled FRET probe for TaqMan PCR: A feasibility study. Biotechnol Appl Biochem. 2022;(April):1-14. [DOI:10.1002/bab.2387] [PMID]
27. Hassan A, Macedo LJA, Souza JCP De, Lima FCDA, Crespi FN. OPEN A combined Far-FTIR , FTIR Spectromicroscopy , and DFT Study of the Effect of DNA Binding on the [ 4Fe4S ] Cluster Site in EndoIII. 2020;1-12. [DOI:10.1038/s41598-020-58531-4] [PMID] []
28. Hashemi F, Mohajeri N, Radnia F, Zarghami N. Design of an efficient fluorescent nanoplatform carrier for hydrophobic drugs along with green carbon dot: Possible application in cancer image-guided drug therapy. Photodiagnosis Photodyn Ther. 2022;37:102738. [DOI:10.1016/j.pdpdt.2022.102738] [PMID]
29. Radnia F, Mohajeri N, Hashemi F, Imani M, Zarghami N. Design and development of folate-chitosan/CD nanogel: An efficient fluorescent platform for Cancer-specific delivery of AntimiR-21. React Funct Polym. 2021;160(August 2020):104814. [DOI:10.1016/j.reactfunctpolym.2021.104814]
30. Mohajeri N, Mostafavi E, Zarghami N. The feasibility and usability of DNA-dot bioconjugation to antibody for targeted in vitro cancer cell fluorescence imaging. Vol. 209, Journal of Photochemistry and Photobiology B: Biology. Elsevier B.V; 2020. 111944 p. [DOI:10.1016/j.jphotobiol.2020.111944] [PMID]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2025 CC BY-NC 4.0 | Iranian Journal of Breast Diseases

Designed & Developed by: Yektaweb